Provectus Biopharmaceuticals (PVCT) Short Interest Ratio & Short Volume $0.11 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Short Interest DataProvectus Biopharmaceuticals (PVCT) has a short interest of 65,600 shares. This marks a 1,626.32% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 251,610 shares to cover all short positions.Current Short Interest65,600 sharesPrevious Short Interest3,800 sharesChange Vs. Previous Month+1,626.32%Dollar Volume Sold Short$7,052.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares420,280,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume286,750 sharesAverage Trading Volume251,610 sharesToday's Volume Vs. Average114% Short Selling Provectus Biopharmaceuticals? Sign up to receive the latest short interest report for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPVCT Short Interest Over TimePVCT Days to Cover Over TimePVCT Percentage of Float Shorted Over Time Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Provectus Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202465,600 shares $7,052.00 +1,626.3%N/A0.2 $0.11 10/15/20243,800 shares $410.02 -93.5%N/A0 $0.11 9/30/202458,700 shares $5,746.73 +3,568.8%N/A0.1 $0.10 9/15/20241,600 shares $159.76 -48.4%N/A0 $0.10 8/31/20243,100 shares $279.00 -91.8%N/A0 $0.09 8/15/202437,800 shares $3,277.26 +404.0%N/A0.1 $0.09 Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/20247,500 shares $768.75 +87.5%N/A0 $0.10 7/15/20244,000 shares $458.80 +700.0%N/A0 $0.11 6/30/2024500 shares $63.05 No ChangeN/A0 $0.13 6/15/2024500 shares $79.50 -87.8%N/A0 $0.16 5/31/20244,100 shares $690.03 +720.0%N/A0 $0.17 5/15/2024500 shares $97.15 -99.7%N/A0 $0.19 4/30/2024142,600 shares $28,377.40 +127.8%N/A0.4 $0.20 4/15/202462,600 shares $10,485.50 -67.2%N/A0.1 $0.17 3/31/2024190,800 shares $34,887.78 +1,700.0%N/A0.3 $0.18 3/15/202410,600 shares $2,299.14 -85.7%N/A0 $0.22 2/29/202474,000 shares $11,003.80 -4.0%N/A0.2 $0.15 2/15/202477,100 shares $10,470.18 +1,780.5%N/A0.2 $0.14 1/15/202416,300 shares $1,677.27 -50.6%N/A0.1 $0.10 12/31/202333,000 shares $3,168.00 +89.7%N/A0.1 $0.10 12/15/202317,400 shares $1,896.60 +3.0%N/A0 $0.11 11/30/202316,900 shares $2,535.00 -46.5%N/A0 $0.15 11/15/202331,600 shares $4,740.00 +179.7%N/A0 $0.15 10/31/202311,300 shares $904.00 +2,160.0%N/A0 $0.08 10/15/2023500 shares $35.00 No ChangeN/A0 $0.07 9/30/2023500 shares $42.25 -94.8%N/A0 $0.08 9/15/20239,600 shares $943.68 +100.0%N/A0.1 $0.10 8/31/20234,800 shares $489.60 -46.1%N/A0 $0.10 8/15/20238,900 shares $845.50 +1,680.0%N/A0 $0.10 7/31/2023500 shares $54.45 -97.8%N/A0 $0.11 7/15/202322,300 shares $2,796.42 -64.6%N/A0.1 $0.13 6/30/202363,000 shares $7,125.30 +63.6%N/A0.1 $0.11 6/15/202338,500 shares $4,581.50 +7,600.0%N/A0.1 $0.12 5/31/2023500 shares $67.95 -99.4%N/A0 $0.14 5/15/202381,400 shares $11,387.86 +13,466.7%N/A0.4 $0.14 4/30/2023600 shares $80.22 -81.3%N/A0 $0.13 4/15/20233,200 shares $489.60 -96.4%N/A0 $0.15 3/31/202389,000 shares $14,685.00 +88,900.0%N/A0.3 $0.17 3/15/2023100 shares $15.40 -99.9%N/A0 $0.15 2/28/2023116,600 shares $18,772.60 +3,051.4%N/A0.3 $0.16“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 2/15/20233,700 shares $395.53 -89.5%N/A0 $0.11 1/31/202335,200 shares $4,509.12 +262.9%N/A0.1 $0.13 1/15/20239,700 shares $1,286.71 +9,600.0%N/A0 $0.13 12/30/2022100 shares $10.83 -99.0%N/A0 $0.11 12/15/202210,000 shares $1,099.00 -66.6%N/A0 $0.11 11/30/202229,900 shares $2,780.70 -45.5%N/A0 $0.09 11/15/202254,900 shares $2,843.82 +54,800.0%N/A0.1 $0.05 10/31/2022100 shares $5.00 No ChangeN/A0 $0.05 10/15/2022100 shares $4.85 No ChangeN/A0 $0.05 9/30/2022100 shares $4.90 -99.6%N/A0 $0.05 9/15/202225,500 shares $1,351.50 +8.5%N/A0.1 $0.05 8/31/202223,500 shares $1,280.75 +2,511.1%N/A0.1 $0.05 8/15/2022900 shares $49.50 +80.0%N/A0 $0.06 7/31/2022500 shares $29.00 +400.0%N/A0 $0.06 7/15/2022100 shares $5.99 -99.6%N/A0 $0.06 6/30/202226,200 shares $1,419.28 +26,100.0%N/A0.1 $0.05 6/15/2022100 shares $5.30 -96.8%N/A0 $0.05 5/31/20223,100 shares $186.00 -54.4%N/A0 $0.06 5/15/20226,800 shares $357.68 +3,300.0%N/A0 $0.05 4/30/2022200 shares $12.28 +100.0%N/A0 $0.06 4/15/2022100 shares $5.86 No ChangeN/A0 $0.06 3/31/2022100 shares $6.74 No ChangeN/A0 $0.07 3/15/2022100 shares $6.92 -96.7%N/A0 $0.07 2/28/20223,000 shares $206.70 +2,900.0%N/A0 $0.07 2/15/2022100 shares $7.00 -98.7%N/A0 $0.07 1/31/20227,700 shares $500.50 -85.4%N/A0 $0.07 1/15/202252,600 shares $3,682.00 +39.2%N/A0.1 $0.07 12/31/202137,800 shares $2,079.00 +37,700.0%N/A0 $0.06 12/15/2021100 shares $5.03 -93.8%N/A0 $0.05 11/30/20211,600 shares $85.76 -61.0%N/A0 $0.05 11/15/20214,100 shares $213.61 +4,000.0%N/A0 $0.05 10/29/2021100 shares $5.62 -99.9%N/A0 $0.06 10/15/202190,700 shares $5,587.12 -24.6%N/A0.4 $0.06 9/30/2021120,300 shares $7,819.50 +55.8%N/A0.3 $0.07 9/15/202177,200 shares $4,863.60 -45.4%N/A0.2 $0.06 8/31/2021141,300 shares $8,619.30 -29.4%N/A0.1 $0.06 8/13/2021200,200 shares $13,913.90 -22.3%N/A0.5 $0.07 7/30/2021257,500 shares $17,896.25 +29.7%N/A1 $0.07 7/15/2021198,600 shares $13,902.00 +13.6%N/A0.4 $0.07 6/30/2021174,900 shares $11,980.65 -3.6%N/A0.7 $0.07 6/15/2021181,500 shares $12,668.70 -10.4%N/A0.3 $0.07 5/28/2021202,600 shares $14,911.36 +9.0%N/A0.5 $0.07 5/14/2021185,800 shares $12,430.02 +16.1%N/A0.6 $0.07 4/30/2021160,000 shares $10,400.00 No ChangeN/A0.3 $0.07 4/15/2021160,000 shares $10,752.00 -14.5%N/A0.5 $0.07 3/31/2021187,200 shares $13,122.72 +10.1%N/A0.3 $0.07 3/15/2021170,000 shares $11,645.00 +6.3%N/A0.5 $0.07 2/26/2021160,000 shares $11,680.00 -34.0%N/A0.3 $0.07 2/12/2021242,400 shares $17,695.20 +25.9%N/A0.3 $0.07 1/29/2021192,600 shares $14,445.00 -54.3%N/A0.1 $0.08“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 1/15/2021299,400 shares $20,898.12 +76.1%N/A0.4 $0.07 12/31/2020160,500 shares $9,292.95 -46.4%N/A0.3 $0.06 12/15/2020299,400 shares $17,514.90 +76.1%N/A0.4 $0.06 11/30/2020170,000 shares $10,880.00 -1.4%N/A0.3 $0.06 11/15/2020172,400 shares $11,585.28 -46.8%N/A0.6 $0.07 10/30/2020324,100 shares $22,038.80 +23.8%N/A0.9 $0.07 10/15/2020261,700 shares $19,889.20 -44.8%N/A0.5 $0.08 9/30/2020473,700 shares $41,022.42 +194.6%N/A0.7 $0.09 9/15/2020160,800 shares $11,674.08 +0.2%N/A0.4 $0.07 8/31/2020160,500 shares $12,968.40 -42.0%N/A0.3 $0.08 8/14/2020276,700 shares $26,148.15 +3,493.5%N/A0.2 $0.09 7/31/20207,700 shares $553.63 -67.4%N/A0 $0.07 7/15/202023,600 shares $1,413.64 +81.5%N/A0.1 $0.06 6/30/202013,000 shares $585.00 +20.4%N/A0 $0.05 6/15/202010,800 shares $509.76 +2,060.0%N/A0 $0.05 5/29/2020500 shares $22.30 -80.0%N/A0 $0.04 5/15/20202,500 shares $105.25 +400.0%N/A0 $0.04 4/30/2020500 shares $21.00 No ChangeN/A0 $0.04 4/15/2020500 shares $24.15 -99.2%N/A0 $0.05 3/31/202061,000 shares $2,440.00 +634.9%N/A0.1 $0.04 3/13/20208,300 shares $498.00 +45.6%N/A0 $0.06 2/28/20205,700 shares $171.00 -79.2%N/A0 $0.03 2/14/202027,400 shares $1,096.00 +103.0%N/A0 $0.04 1/31/202013,500 shares $810.00 -2.2%N/A0 $0.06 1/15/202013,800 shares $924.60 -33.3%N/A0 $0.07 12/31/201920,700 shares $1,242.00 -95.9%N/A0 $0.06 PVCT Short Interest - Frequently Asked Questions What is Provectus Biopharmaceuticals' current short interest? Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 65,600 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest. Is Provectus Biopharmaceuticals' short interest increasing or decreasing? Provectus Biopharmaceuticals saw a increase in short interest in October. As of October 31st, there was short interest totaling 65,600 shares, an increase of 1,626.3% from the previous total of 3,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Provectus Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Provectus Biopharmaceuticals: ADC Therapeutics SA (3.28%), Zura Bio Limited (4.14%), Compass Therapeutics, Inc. (2.09%), Heron Therapeutics, Inc. (18.94%), Inozyme Pharma, Inc. (7.40%), Kyverna Therapeutics, Inc. (13.71%), Caribou Biosciences, Inc. (12.43%), Nkarta, Inc. (13.56%), Tenaya Therapeutics, Inc. (7.99%), Galectin Therapeutics Inc. (12.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Provectus Biopharmaceuticals stock? Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Provectus Biopharmaceuticals? A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further. How often is Provectus Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ADCT Short Interest Data ZURA Short Interest Data CMPX Short Interest Data HRTX Short Interest Data INZY Short Interest Data KYTX Short Interest Data CRBU Short Interest Data NKTX Short Interest Data TNYA Short Interest Data GALT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PVCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PVCT Stock Alerts